Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Other Non-Current Assets (2016 - 2025)

Macrogenics (MGNX) has disclosed Other Non-Current Assets for 14 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 10.99% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 10.99% decrease, with the full-year FY2025 number at $1.4 million, down 10.99% from a year prior.
  • Other Non-Current Assets was $1.4 million for Q4 2025 at Macrogenics, down from $1.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $20.3 million in Q1 2021 to a low of $1.2 million in Q1 2024.
  • A 5-year average of $6.3 million and a median of $1.4 million in 2021 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: plummeted 94.17% in 2021, then increased 25.74% in 2025.
  • Macrogenics' Other Non-Current Assets stood at $1.4 million in 2021, then decreased by 1.22% to $1.4 million in 2022, then increased by 0.58% to $1.4 million in 2023, then grew by 12.27% to $1.6 million in 2024, then decreased by 10.99% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Other Non-Current Assets are $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025).